-+ 0.00%
-+ 0.00%
-+ 0.00%

AXSOME THERAPEUTICS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $245 FROM $265

Reuters·10/08/2026 11:07:26

Please log in to view news